Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 18851 - 18875 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Copper	Approved Investigational	MYLK	4638	upregulated	[NSC 689534 binds to Copper] which results in increased expression of MYLK mRNA	3q21.1	A21749
Copper	Approved Investigational	MYO5A	4644	upregulated	[NSC 689534 binds to Copper] which results in increased expression of MYO5A mRNA	15q21.2	A21749
Copper	Approved Investigational	N4BP2	55728	upregulated	[NSC 689534 binds to Copper] which results in increased expression of N4BP2 mRNA	4p14	A21749
Copper	Approved Investigational	N4BP2L2	10443	upregulated	[NSC 689534 binds to Copper] which results in increased expression of N4BP2L2 mRNA	13q13.1	A21749
Copper	Approved Investigational	NAA15	80155	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of NAA15 mRNA	4q31.1	A21749
Copper	Approved Investigational	NAA38	84316	upregulated	[NSC 689534 binds to Copper] which results in increased expression of NAA38 mRNA	17p13.1	A21749
Copper	Approved Investigational	NAA40	79829	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of NAA40 mRNA	11q13.1	A21749
Copper	Approved Investigational	NACC1	112939	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of NACC1 mRNA	19p13.13	A21749
Copper	Approved Investigational	NALCN	259232	upregulated	[NSC 689534 binds to Copper] which results in increased expression of NALCN mRNA	13q32.3-q33.1	A21749
Copper	Approved Investigational	NANOS1	340719	upregulated	[NSC 689534 binds to Copper] which results in increased expression of NANOS1 mRNA	10q26.11	A21749
Copper	Approved Investigational	NAP1L2	4674	upregulated	[NSC 689534 binds to Copper] which results in increased expression of NAP1L2 mRNA	Xq13.2	A21749
Copper	Approved Investigational	NASP	4678	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of NASP mRNA	1p34.1	A21749
Copper	Approved Investigational	NAT10	55226	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of NAT10 mRNA	11p13	A21749
Copper	Approved Investigational	NAT14	57106	upregulated	[Disulfiram binds to Copper] which results in increased expression of NAT14 mRNA	19q13.42	A21750
Copper	Approved Investigational	NAT14	57106	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of NAT14 mRNA	19q13.42	A21749
Copper	Approved Investigational	NAV3	89795	upregulated	[NSC 689534 binds to Copper] which results in increased expression of NAV3 mRNA	12q21.2	A21749
Copper	Approved Investigational	NBPF3	84224	upregulated	[Disulfiram binds to Copper] which results in increased expression of NBPF3 mRNA	1p36.12	A21750
Copper	Approved Investigational	NBR2	10230	upregulated	[NSC 689534 binds to Copper] which results in increased expression of NBR2 mRNA	17q21.31	A21749
Copper	Approved Investigational	NCAPD2	9918	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of NCAPD2 mRNA	12p13.31	A21749
Copper	Approved Investigational	NCAPD3	23310	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of NCAPD3 mRNA	11q25	A21749
Copper	Approved Investigational	NCAPG	64151	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of NCAPG mRNA	4p15.31	A21749
Copper	Approved Investigational	NCAPH	23397	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of NCAPH mRNA	2q11.2	A21749
Copper	Approved Investigational	NCEH1	57552	upregulated	[Disulfiram binds to Copper] which results in increased expression of NCEH1 mRNA	3q26.31	A21750
Copper	Approved Investigational	NCF2	4688	upregulated	[NSC 689534 binds to Copper] which results in increased expression of NCF2 mRNA	1q25.3	A21749
Copper	Approved Investigational	NCOA3	8202	upregulated	[NSC 689534 binds to Copper] which results in increased expression of NCOA3 mRNA	20q13.12	A21749

Displaying entries 18851 - 18875 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability